Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara Martin

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cancer Letters|September 28, 2024
Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinomaFaye Lewis, James Beirne, Brian Henderson, et al.
The Journal of Liquid Biopsy|July 11, 2026
A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patientsBrian D Henderson, Lauren McMahon, Faye Lewis, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cancer Letters|September 28, 2024
Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinomaFaye Lewis, James Beirne, Brian Henderson, et al.
The Journal of Liquid Biopsy|July 11, 2026
A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patientsBrian D Henderson, Lauren McMahon, Faye Lewis, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 5